Onderzoeker
Rik
- Trefwoorden:Geneeskunde
- Disciplines:Natuurwetenschappen
Affiliaties
- Hematologie (Departement)
Lid
Vanaf1 jul 2012 → Heden - Hematologie (Onderzoeksgroep)
Lid
Vanaf1 okt 2003 → Heden - Observerende Klinische wetenschappen (Departement)
Lid
Vanaf8 apr 2019 → Heden - Observerende Klinische wetenschappen (Departement)
Lid
Vanaf1 jan 2014 → 20 okt 2022 - Laboratorium voor Moleculaire en Cellulaire Therapie (Onderzoeksgroep)
Lid
Vanaf28 feb 2013 → 1 okt 2019 - Immunologie en Microbiologie (Departement)
Lid
Vanaf1 dec 2006 → 31 dec 2013 - Immunologie en Microbiologie (Departement)
Lid
Vanaf1 dec 2003 → 30 sep 2006
Publicaties
1 - 10 van 56
- Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma(2023)
Auteurs: Maria-Victoria Mateos, Sophie Rigaudeau, Supratik Basu, Ivan Spicka, Rik Schots, Tomasz Wrobel, Gordon Cook, Meral Beksac, Katharine S Gries, Anupa Kudva, et al.
Pagina's: 1172-1177 - Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms(2023)
Auteurs: Guillermo Ortí, Luuk Gras, Nienke Zinger, Maria Chiara Finazzi, Katja Sockel, Marie Robin, Edouard Forcade, Daniele Avenoso, Nicolaus Kröger, Jürgen Finke, et al.
Pagina's: 628-638 - Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis(2023)
Auteurs: Myrthe J van Dijk, Brigitte A van Oirschot, Manon C Stam-Slob, Esmé Waanders, Bert van der Zwaag, Eduard J van Beers, Judith J M Jans, Peter Willem van der Linden, Jose M Torregrosa Diaz, Betty Gardie, et al.
Pagina's: 249-255 - Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors(2023)
Auteurs: Yves Chalandon, Giulia Sbianchi, Luuk Gras, Linda Koster, Jane F. Apperley, Jenny L. Byrne, Urpu Salmenniemi, Henrik Sengeloev, Mahmoud Aljurf, Grzegorz Helbig, et al.
Pagina's: 112-121 - Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1)(2022)
Auteurs: Meletios A Dimopoulos, Paul G Richardson, Nizar J Bahlis, Sebastian Grosicki, Michele Cavo, Meral Beksaç, Wojciech Legieć, Anna M Liberati, Hartmut Goldschmidt, Andrew Belch, et al.
Pagina's: 403-414 - Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals(2022)
Auteurs: Jana Vanden Broeck, Katrien Beeckman, Evelyne Van Gastel, Luc De Keersmaecker, Timothy Devos, Christiane Gérard, Lucien Noens, Dominique Putzeys, Karin Van Poucke, Margareta Haelterman, et al.
Pagina's: 259-267 - Validation of a PCR-based next-generation sequencing approach for the detection and quantification of minimal residual disease in acute lymphoblastic leukemia and multiple myeloma using gBlocks as calibrators(2021)
Auteurs: Jona Van der Straeten, Wouter De Brouwer, Emmanuelle Kabongo Kanjinga, Marie-Françoise Dresse, Karel Fostier, Rik Schots, Ivan Van Riet, M.H.C. Bakkus
Pagina's: 599-611 - Efficacy of high-dose anakinra in refractory macrophage activation syndrome in adult-onset Still's disease(2020)
Auteurs: Sofia Ajeganova, Ann De Becker, Rik Schots
Pagina's: 1-9 - Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes(2020)
Auteurs: Ingrid Segers, Erlisa Bardhi, Ileana Mateizel, Ellen Van Moer, Rik Schots, Greta Verheyen, Herman Tournaye, Michel De Vos
Pagina's: 2026-2036 - Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation(2020)
Auteurs: Simone Cesaro, Gloria Tridello, Steffie van der Werf, Peter Bader, Gerard Sociè, Per Ljungman, Grant McQuaker, Stefano Giardino, Duygu Uckan-Cetinkaya, Achilles Anagnostopoulos, et al.
Pagina's: 110-116